Dr. Triparna Sen is an Associate Professor, in the Department of Oncological Sciences, and the Co-Director of the Lung Cancer PDX Platform at the Icahn School of Medicine at Mount Sinai, New York. The Sen lab focuses on the development of new treatment paradigms for clinically relevant molecular subsets of lung cancer, using genetic and transcriptomic analyses; functional genomics; and patient-derived models of lung cancer. Previously, Dr. Sen identified that DNA damage response (DDR) proteins are effective therapeutic targets for small-cell lung cancer treatment and that targeting DDR promotes antitumor immunity through the activation of innate immune signaling. In her recent work, Dr. Sen identified molecular determinants and novel therapeutic targets for lineage plasticity in lung cancer.
Dr. Sen has received several prestigious awards including- AAAS Martin and Rose Wachtel Cancer Research Award (2021); 40 under 40 in Cancer- Emerging Leaders Award (2020); AACR Women in Cancer Research Scholar Award; AACR Scholar-in-training award; Jeffrey Lee Cousins fellowship and Immuno-Oncology-Young Investigator award.